Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Anika Therapeutics (ANIK) Other Gross PP&E Adjustments (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Other Gross PP&E Adjustments for 16 consecutive years, with $64.0 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 12.09% to $64.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.0 million through Dec 2025, up 12.09% year-over-year, with the annual reading at $64.0 million for FY2025, 12.09% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $64.0 million at Anika Therapeutics, up from -$26.0 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $65.1 million in Q2 2025, with the low at -$34.8 million in Q2 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $2.1 million, with a median of -$24.4 million recorded in 2021.
  • The sharpest move saw Other Gross PP&E Adjustments tumbled 59.13% in 2022, then surged 308.31% in 2025.
  • Over 5 years, Other Gross PP&E Adjustments stood at $62.6 million in 2021, then decreased by 3.22% to $60.6 million in 2022, then decreased by 14.87% to $51.6 million in 2023, then rose by 10.67% to $57.1 million in 2024, then rose by 12.09% to $64.0 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $64.0 million, -$26.0 million, and $65.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.